RAAP Policy Study: Medicare's "Maximum Fair Price" Is Not a Transferable Model for State Drug Pricing
PR Newswire —
WASHINGTON, Feb. 18, 2026 /PRNewswire/ -- As states explore new strategies to address prescription drug affordability, the Rare Access Action Project (RAAP) today released an issue paper warning policymakers against attempting to replicate Medicare's Maximum Fair Price (MFP) framework at...